Regorafenib (CAS: 755037-03-7), sold under the brand name Stivarga among others, is an oral multi-kinase inhibitordeveloped by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK).
Regorafenib (CAS: 755037-03-7), ຂາຍພາຍໃຕ້ຊື່ຍີ່ຫໍ້ Stivarga ແລະອື່ນໆ, ແມ່ນທາງປາກ inhibitor ຫຼາຍ kinase ຖືກພັດທະນາໂດຍ Bayer ເຊິ່ງແນໃສ່ການຕອບສະ ຫນອງ ຢາຕ້ານເຊື້ອໂຣກໂຣກໂຣກໂຣກໂຣກໂຣກໂຣກໂຣກໂຣກໂຣກ (ໂຣກໂຣກໂຣກໂຣກໂຣກໂຣກໂຣກ (receptor tyrosine kinase) (RTK).